Allergy

Biosimilars

Cardiology

Dermatology

Endocrinology

Family Medicine

Gastroenterology

Geriatrics

Hospital Medicine

Infectious Disease

Internal Medicine

Nephrology

Neurology

Obesity Management

Ophthalmology

Pain

Pediatrics

Psychiatry

Pulmonology

Rare Disease Report®

Rheumatology

Sleep

Surgery

Women's Health

News

Media

Medical World News

Podcasts

Shows

State Of Sciences - Presentations

Videos

Webinars

Multimedia Series

Insights

Medcast Podcasts

Medcast Videos

Peer Exchange

Peers & Perspectives

Conferences

Conference Coverage

Conference Listing

Partners

CME/CE

Resources

Interactive Tools

Live Events

Press Release

Publications

Subscribe

Connor Iapoce is an associate editor for 

 and joined the MJH Life Sciences team in April 2021. He graduated from The College of New Jersey with a degree in Journalism and Professional Writing. He enjoys listening to records, going to concerts, and playing with his cat Squish. You can reach him at 

Articles

A sugary drinks tax in England may have prevented over 5,000 cases of obesity a year in older girls, but had no significant association with obesity levels in year six boys or younger children. 


Sugary Drinks Tax May Be Effective In Preventing Childhood Obesity 

Lana Dykes is the editor of HCPLive Rheumatology. She is an experienced editor and technical writer with a demonstrated history of working in the banking and publishing industries. In her free time, she enjoys cooking, yoga, listening to podcasts, and drawing. She can be reached via email at LDykes@mjhlifesciences.com.

The approval of the adalimumab biosimilar, adalimumab-aacf, signals the beginning of Fresenius Kabi's long-term dedication to biosimilars.


Biosimilar Adalimumab-aacf Gains FDA Approval, Marks Growing Interest in Biosimilar Development 

The clinical trials that supported the FDA decision, SEQUOIA and ALPINE, evaluated the efficacy of zanubrutinib and findings paved the way to add the therapy as a treatment option.

Ian Flinn, MD, PhD: Zanubrutinib for Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

A ED screening program identified a substantial number of patients with undiagnosed prediabetes and T2D or undermanaged disease, particularly racial and ethnic minorities. 

Emergency Department Screening Program Useful in Identifying Undiagnosed Diabetes 

HCPLive is a comprehensive clinical news and information portal that provides physicians with up-to-date specialty and disease-specific resources designed to help them provide better care to patients. At HCPLive, you will find breaking news, video interviews with physician experts, in-depth conference coverage, finance and practice management updates, insight and analysis from physician contributors, and more.

InTheNEWS

Evaluation and Management of Rheumatic Diseases: A Case-Based Review

Unclear Benefits for Dementia Screenings at Nursing Homes

Complex but Crucial: Enhancing Epilepsy Treatment at UCSF

Improving Therapeutic Options for Patients With PTSD

Promise and Pitfalls of Preventing Migraine With CGRP Inhibitors

ZTlido Lowers Doses While Raising Efficacy

Evaluation and Management of Rheumatic Diseases: A Case-Based Review

Unclear Benefits for Dementia Screenings at Nursing Homes

Complex but Crucial: Enhancing Epilepsy Treatment at UCSF

Improving Therapeutic Options for Patients With PTSD

Promise and Pitfalls of Preventing Migraine With CGRP Inhibitors

ZTlido Lowers Doses While Raising Efficacy

Evaluation and Management of Rheumatic Diseases: A Case-Based Review

Unclear Benefits for Dementia Screenings at Nursing Homes

Complex but Crucial: Enhancing Epilepsy Treatment at UCSF

Improving Therapeutic Options for Patients With PTSD

Promise and Pitfalls of Preventing Migraine With CGRP Inhibitors

ZTlido Lowers Doses While Raising Efficacy